Kindeva snags $226M in chemical threat prep deal with US
Kindeva's Meridian Medical Technologies subsidiary landed a $226 million deal with the US government to supply a nerve-agent antidote, expanding its chemical-threat preparedness work.
Kindeva Drug Delivery
Private
Kindeva Drug Delivery is a contract development and manufacturing organization specializing in sterile injectables, inhalation and dermal drug delivery, and its Meridian Medical Technologies subsidiary supplies medical countermeasures such as nerve-agent antidote autoinjectors to the US government.
Company Info
Sector:CDMO / Drug Delivery
Headquarters:St. Paul, Minnesota, USA
Founded:2020
Website:www.kindevadd.com/